Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Ildong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	72,267	53,258	52,146	135,586	85,564
Short-Term Investments	12,605	28,021	16,600	19,095	600
Trading Asset Securities	-	-	10,000	-	-
Cash & Short-Term Investments	84,872	81,279	78,746	154,681	86,164
Cash Growth	4.42%	3.22%	-49.09%	79.52%	-4.85%
Accounts Receivable	44,613	56,245	53,916	51,818	49,517
Other Receivables	10,073	2,735	4,158	3,026	1,241
Receivables	66,977	62,650	58,074	54,844	50,758
Inventory	87,939	84,623	98,249	82,587	89,227
Prepaid Expenses	2,150	1,623	1,270	1,363	1,408
Other Current Assets	5,053	5,506	45,697	7,008	5,686
Total Current Assets	246,991	235,681	282,035	300,485	233,243
Property, Plant & Equipment	221,443	256,380	255,317	247,790	256,419
Long-Term Investments	23,729	18,996	21,395	22,432	21,675
Goodwill	5,527	5,527	5,527	5,527	-
Other Intangible Assets	22,681	30,079	31,401	38,926	38,283
Long-Term Accounts Receivable	277.35	442.14	542.83	-	-
Long-Term Deferred Tax Assets	55,670	53,888	43,822	66,016	24,935
Long-Term Deferred Charges	6,151	6,505	10,193	22,174	24,788
Other Long-Term Assets	4,590	1,689	3,630	3,808	4,213
Total Assets	589,043	611,261	655,810	708,970	605,277
Accounts Payable	47,616	50,250	46,099	38,334	35,988
Accrued Expenses	30,985	33,277	33,734	34,930	20,804
Short-Term Debt	122,647	176,497	140,743	88,400	65,400
Current Portion of Long-Term Debt	3,443	13,000	1,000	42,000	23,000
Current Portion of Leases	4,606	3,575	6,618	4,035	3,956
Current Income Taxes Payable	1,475	68.3	268.05	7.55	129.16
Current Unearned Revenue	-	-	-	600	-
Other Current Liabilities	57,969	64,728	82,182	149,456	35,733
Total Current Liabilities	268,739	341,395	310,644	357,763	185,010
Long-Term Debt	56,208	3,000	16,000	60,404	42,000
Long-Term Leases	18,644	16,654	43,387	31,316	32,500
Long-Term Deferred Tax Liabilities	393.05	1.43	6.06	-	-
Other Long-Term Liabilities	12,623	8,644	9,688	10,375	10,328
Total Liabilities	422,758	431,880	451,940	542,008	350,730
Common Stock	28,063	28,063	26,803	23,803	23,803
Additional Paid-In Capital	173,327	173,359	377,287	210,262	209,614
Retained Earnings	-50,942	-58,540	-211,102	-81,951	14,856
Treasury Stock	-2,307	-2,307	-365.05	-365.05	-365.05
Comprehensive Income & Other	12,618	28,968	-1,379	1,159	6,640
Total Common Equity	160,758	169,543	191,244	152,909	254,547
Minority Interest	-1,701	4,723	6,981	7,676	-
Shareholders' Equity	166,285	179,381	203,870	166,962	254,547
Total Liabilities & Equity	589,043	611,261	655,810	708,970	605,277
Total Debt	205,548	212,726	207,748	226,155	166,856
Net Cash (Debt)	-120,675	-131,447	-129,002	-71,474	-80,692
Net Cash Per Share	-4324.69	-4862.97	-4896.88	-3004.97	-3392.40
Filing Date Shares Outstanding	27.93	27.93	26.79	23.79	23.79
Total Common Shares Outstanding	27.93	27.93	26.79	23.79	23.79
Working Capital	-21,748	-105,713	-28,609	-57,279	48,233
Book Value Per Share	5755.27	6069.76	7139.87	6428.69	10701.87
Tangible Book Value	132,550	133,936	154,315	108,456	216,264
Tangible Book Value Per Share	4745.41	4795.03	5761.20	4559.77	9092.34
Land	50,816	72,561	35,125	35,125	35,125
Buildings	140,049	141,614	140,941	140,732	138,731
Machinery	202,503	211,982	206,257	195,601	185,845
Construction In Progress	1,393	3,694	1,963	3,683	5,988

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.